TheEdgeResearch
Home / Stocks / TKUN.TA

Tikun Olam-Cannbit Pharmaceuticals Ltd. (TKUN.TA)

TLV Healthcare Drug Manufacturers - Specialty & Generic
$180.00 ▼ -9.09%
Market Cap
$1.5M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.72
52-Wk Range
170-4000
CEO
Ronen Elad
Country
IL
Currency
ILA

Tikun Olam-Cannbit Pharmaceuticals Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Nof HaGalil, TA, IL. The stock last traded at $180.00, down 9.09% on the session, giving a market capitalisation of $1.5M. Its beta of 0.72 implies it has historically moved less than the broad market.

Company profile
Exchange
Tel Aviv Stock Exchange
Employees
4
IPO date
2002-08-12
Headquarters
Nof HaGalil, TA, IL
About Tikun Olam-Cannbit Pharmaceuticals Ltd.

Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers clinical research, training, and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd was founded in 2006 and is based in Nof HaGalil, Israel.

Comparable companies

Tikun Olam-Cannbit Pharmaceuticals Ltd. is most often compared with the following Healthcare names:

ALMD.TABIOV.TABOLT.TAEMTC-M.TAEVGN.TAIDNT.TAMRHL.TAPLNT.TATGTR.TAXTLB.TA
More research on TKUN.TA
TKUN.TA technical analysis TKUN.TA TheEdge Score Compare against peers
Open full interactive analysis & DCF →